| Timeframe | Predicted Price | Past | Historical | Insight |
|---|---|---|---|---|
| Tomorrow | $5.38 ▲ +2.03% | Yesterday | $5.23 ▼ -0.85% | Tomorrow's Polaryx Therapeutics Inc. Common Stock (PLYX) setup is anchored to $5.27 and targets $5.38 (+2.03%). The near-term read is upside; watch $5.43 / $5.11 because daily realized volatility is about 8.00%. |
Tomorrow's Polaryx Therapeutics Inc. Common Stock (PLYX) setup is anchored to $5.27 and targets $5.38 (+2.03%). The near-term read is upside; watch $5.43 / $5.11 because daily realized volatility is about 8.00%. | ||||
| Week | $5.60 ▲ +6.31% | Last Week | $5.13 ▼ -2.65% | The 7-day Polaryx Therapeutics Inc. Common Stock model moves from $5.13 to $5.60 (+6.31%). It gives upside momentum context for this stock, so breaks around $5.43 / $5.11 matter more than a single tick. |
The 7-day Polaryx Therapeutics Inc. Common Stock model moves from $5.13 to $5.60 (+6.31%). It gives upside momentum context for this stock, so breaks around $5.43 / $5.11 matter more than a single tick. | ||||
| Month | $5.98 ▲ +13.45% | Last Month | $4.97 ▼ -5.65% | The 1-month Polaryx Therapeutics Inc. Common Stock target is $5.98 (+13.45%), compared with the live reference near $5.27. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. |
The 1-month Polaryx Therapeutics Inc. Common Stock target is $5.98 (+13.45%), compared with the live reference near $5.27. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. | ||||
| Year | $6.54 ▲ +24.14% | Last Year | $4.74 ▼ -10.14% | The 1-year Polaryx Therapeutics Inc. Common Stock scenario points to $6.54 (+24.14%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. |
The 1-year Polaryx Therapeutics Inc. Common Stock scenario points to $6.54 (+24.14%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. | ||||
| 5 Years | $7.86 ▲ +49.20% | 5 Years Ago | $4.18 ▼ -20.66% | The 5-year Polaryx Therapeutics Inc. Common Stock view is $7.86 (+49.20%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. |
The 5-year Polaryx Therapeutics Inc. Common Stock view is $7.86 (+49.20%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. | ||||
| Indicator | Value | Signal |
|---|---|---|
| Price | $5.27 | Mid |
| Daily Change | -7.54% | Below |
| Volatility Cap | 20.0% | Mid |
| Confidence | 74% | Above |
| Data Source | nasdaq-screener | Mid |
| Current | $5.27 | Daily Change | -7.54% |
| Market Cap | $249.50M | Source | nasdaq-screener |
Related ideas for internal navigation, grouped by stronger upside and weaker downside setups in the same market.